Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TPMT | P51580 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA7 | P43166 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1859003 | 0.96 | TPMT (0.39) | TPMTCYP1A2CA12CA1CA2 | |
| SCHEMBL9600105 | 0.96 | TPMT (0.39) | TPMTCYP1A2CA12CA1CA2 | |
| SCHEMBL8855992 | 0.96 | TPMT (0.39) | TPMTCYP1A2CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL8541347 | 0.96 | TPMT (0.39) | TPMTCYP1A2CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL8824728 | 0.93 | TPMT (0.38) | TPMTCYP1A2CA12CA1CA2 | |
| SCHEMBL8537633 | 0.93 | TPMT (0.38) | TPMTCYP1A2CA12CA1CA2 | |
| SCHEMBL4587818 | 0.92 | TPMT (0.41) | TPMTCYP1A2CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL8536294 | 0.90 | TPMT (0.36) | TPMTCYP1A2CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL9787611 | 0.89 | TPMT (0.39) | TPMTCYP1A2CA12CA1CA2 | |
| SCHEMBL4265757 | 0.89 | TPMT (0.39) | TPMTCYP1A2CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118684589-A | Preparation method of iodine-containing polyol | 宁波贝昂生物材料有限公司 | 2024-09-24 | — | — | CN | claimed |
| CN-117887086-A | Application of halogen functionalized metal organic framework material in storage and delivery of fluorine-containing electron special gas | 华为技术有限公司 | 2024-04-16 | — | — | CN | claimed |
| WO-2024074141-A1 | POROUS MATERIAL AND APPLICATION THEREOF | 华为技术有限公司 | 2024-04-11 | — | — | WO | claimed |
| CN-116875024-A | Hydrogel with X-ray visibility and preparation method and application thereof | 赛克赛斯生物科技股份有限公司 | 2023-10-13 | — | — | CN | claimed |
| US-10342232-B1 | Iodinated polymers for biological agent defeat | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 2019-07-09 | — | — | US | claimed |
| EP-0618189-B1 | Iodinated aromatic propanedioates and their use as X-ray contrast agents | NANOSYSTEMS LLC (US) | 1997-06-04 | — | — | EP | claimed |
| EP-0767779-A1 | ALPHA-(CYCLOALKYL, ARYL AND ARALKYL)SUBSTITUTED POLYIODINATED AROYLOXY COMPOUNDS | NanoSystems L.L.C. (US) | 1997-04-16 | — | — | EP | claimed |
| EP-0756497-A1 | X-RAY CONTRAST COMPOSITIONS CONTAINING PHARMACEUTICALLY ACCEPTABLE CLAYS | NYCOMED IMAGING AS (NO) | 1997-02-05 | — | — | EP | claimed |
| EP-0749414-A1 | IODINATED AROYLOXY KETONES | NanoSystems L.L.C. (US) | 1996-12-27 | — | — | EP | claimed |
| EP-0746339-A1 | X-RAY CONTRAST COMPOSITIONS CONTAINING CELLULOSE DERIVATIVES | NYCOMED IMAGING AS (NO) | 1996-12-11 | — | — | EP | claimed |
| US-5330739-A | Iodinated benzoyl acetals and ketals for x-ray imaging | STERLING WINTHROP INC. (US) | 1994-07-19 | — | — | US | claimed |
| US-5328404-A | Contrast agents | STERLING WINTHROP INC. (US) | 1994-07-12 | — | — | US | claimed |
| EP-0603917-A1 | Iodinated agents and X-ray imaging compositions containing them | NanoSystems L.L.C. (US) | 1994-06-29 | — | — | EP | claimed |
| EP-0603922-A1 | Iodinated aroyloxy esters and their use as contrast agents in X-ray imaging | NanoSystems L.L.C. (US) | 1994-06-29 | — | — | EP | claimed |
| EP-0603923-A1 | Iodinated aromatic acid derivatives and their use as contrast agents in X-ray imaging | NanoSystems L.L.C. (US) | 1994-06-29 | — | — | EP | claimed |
| EP-0601616-A1 | Iodinated aroyloxy carboxamides and contrast agents containing them | NanoSystems L.L.C. (US) | 1994-06-15 | — | — | EP | claimed |
| EP-0601617-A1 | Iodinated benzoyl acetals and ketals, and contrast agents containing them | NanoSystems L.L.C. (US) | 1994-06-15 | — | — | EP | claimed |
| US-5318768-A | For gastrointestinal tract; film membrane, cation potentiator, particle surface modifier | STERLING WINTHROP INC. (US) | 1994-06-07 | — | — | US | claimed |
| US-5264610-A | X-ray contrast agents | STERLING WINTHROP INC. (US) | 1993-11-23 | — | — | US | claimed |
| US-5260478-A | Contrast agents in x-ray imaging compositions; medical diagnosis | STERLING WINTHROP INC. (US) | 1993-11-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10342232-B1 | Iodinated polymers for biological agent defeat | TBCA, HSP90AB2P, LRBA | TPMT 3983/4885CYP1A2 3562/4885CA12 1031/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.